Abstract
This study describes the synthesis of four 2,4,5-triarylimidazole derivatives and their anticancer activities. The target compounds were prepared from the reaction of benzaldehyde and benzoin derivatives in presence of ammonium acetate and ammonium vanadate. All the synthesized compounds were screened for anticancer activities against T47D and MDA-MB231 cell lines using the MTT assay. However, our obtained results indicated a significant difference between colchicines cytotoxicity and their homologs on treated MDA-MB231 and T47D cells; one compound (4a) showed a significant IC50 on MDA-MB231 cells in cell culture assay.
Keywords: 2, 4, 5-triarylimidazole, Synthesis, Anticancer, Cytotoxicity, T47D, MDA-MB231.
Letters in Drug Design & Discovery
Title:Synthesis and Anticancer Activity of 2,4,5-triaryl Imidazole Derivatives
Volume: 11 Issue: 7
Author(s): Fatemeh Elahian, Morteza Akbari, Maryam Ghasemi, Neda Behtooee, Mohaddeseh Taheri and Mohsen Amini
Affiliation:
Keywords: 2, 4, 5-triarylimidazole, Synthesis, Anticancer, Cytotoxicity, T47D, MDA-MB231.
Abstract: This study describes the synthesis of four 2,4,5-triarylimidazole derivatives and their anticancer activities. The target compounds were prepared from the reaction of benzaldehyde and benzoin derivatives in presence of ammonium acetate and ammonium vanadate. All the synthesized compounds were screened for anticancer activities against T47D and MDA-MB231 cell lines using the MTT assay. However, our obtained results indicated a significant difference between colchicines cytotoxicity and their homologs on treated MDA-MB231 and T47D cells; one compound (4a) showed a significant IC50 on MDA-MB231 cells in cell culture assay.
Export Options
About this article
Cite this article as:
Elahian Fatemeh, Akbari Morteza, Ghasemi Maryam, Behtooee Neda, Taheri Mohaddeseh and Amini Mohsen, Synthesis and Anticancer Activity of 2,4,5-triaryl Imidazole Derivatives, Letters in Drug Design & Discovery 2014; 11 (7) . https://dx.doi.org/10.2174/1570180811666140313233659
DOI https://dx.doi.org/10.2174/1570180811666140313233659 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
RNAi Screening Identifies TAK1 as a Potential Target for the Enhanced Efficacy of Topoisomerase Inhibitors
Current Cancer Drug Targets Efficient Growth Inhibition of Human Osteosarcoma Cells Using a Peptide Derived from the MDM-2-Binding Site of p53
Protein & Peptide Letters Poly (ADP-Ribose) Polymerase-1 (PARP-1) as Immune Regulator
Endocrine, Metabolic & Immune Disorders - Drug Targets Antiapoptotic Drugs: A Therapautic Strategy for the Prevention of Neurodegenerative Diseases
Current Pharmaceutical Design γ δ T Cell Modulation in Anticancer Treatment
Current Cancer Drug Targets Prediction of the Estrogen Receptor Binding Affinity for both hER<sub>α</sub> and hER<sub>β</sub> by QSAR Approaches
Letters in Drug Design & Discovery Comparative Study of Encoder-decoder-based Convolutional Neural Networks in Cartilage Delineation from Knee Magnetic Resonance Images
Current Medical Imaging Sleep and COPD
Current Respiratory Medicine Reviews A Fresh Prospect of Extracellular Matrix Hydrolytic Enzymes and Their Substrates
Current Pharmaceutical Design An Antifungal Peptide with Antiproliferative Activity Toward Tumor Cells from Red Kidney Beans
Protein & Peptide Letters Cyclopeptides from Marine Organisms
Mini-Reviews in Organic Chemistry Molecular Imprinting-Based Chemiluminescence Techniques in Pharmaceutical Analysis
Current Pharmaceutical Analysis Obesity and Arterial Compliance Alterations
Current Vascular Pharmacology Immune Responses to Lentiviral Vectors
Current Gene Therapy ATP-Binding Cassette Transporters in Inflammatory Brain Disease
Current Pharmaceutical Design IAPs as a Target for Anticancer Therapy
Current Cancer Drug Targets Antidiabetic Oils
Current Diabetes Reviews PI3K Pathway Inhibitors: Better Not Left Alone
Current Pharmaceutical Design Apoptosis Following Photodynamic Tumor Therapy: Induction, Mechanisms and Detection
Current Pharmaceutical Design From Nucleic Acids to Drug Discovery: Nucleobases as Emerging Templates for Drug Candidates
Current Medicinal Chemistry